Showing results (641-650 of 731) with videos related to

Sort By:
Pageof 74
Annals of Thoracic Surgery Short Reports|January 10, 2025
Endobronchial Valves for Management of Persistent Air Leaks in Patients With Chronic Lung DiseasePatrick M Dugom, Danel Mayan, Brandon S Peine, et al.
Annals of Clinical and Translational Neurology|May 20, 2026
Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral SclerosisArne Mueller, Vanessa Vallejo, Mónica Povedano Panadés, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'IvoireEric N Ouattara, Eric L Ross, Yazdan Yazdanpanah, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|May 16, 2002
[Bacillary angiomatosis in an adult infected with HIV-1 at an early stage of immunodepression in Abidjan, Côte d'Ivoire]K A Minga, I Gberi, M B Boka, et al.
Antiviral Therapy|April 29, 2022
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4<sup>+</sup> cell countsGérard M Kouamé, Delphine Gabillard, Raoul Moh, et al.
Cancers|August 29, 2024
Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential TherapyJavier C Angulo, Gorka Larrinaga, David Lecumberri, et al.
Nature Communications|October 11, 2024
An automated network-based tool to search for metabolic vulnerabilities in cancerLuis V Valcárcel, Edurne San José-Enériz, Raquel Ordoñez, et al.
International Journal of Molecular Sciences|November 27, 2025
Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell CarcinomaMaría Riaza Montes, Beatriz Suárez, Jon Danel Solano-Iturri, et al.
AIDS Research and Therapy|March 1, 2016
High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialCalixte Guehi, Anani Badjé, Delphine Gabillard, et al.
Pageof 74